Financial

LimFlow Raises $40 Million (€36 Million) in Series D Financing

Funds to Support Completion of Clinical Program Through Commercialization of Novel Device Designed to Prevent Amputations in Patients with Chronic Limb-Threatening Ischemia PARIS–(BUSINESS WIRE)–LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), today announced […]

Former WHOOP and Fitbit Executives Join CardieX Group Company CONNEQT Health to Drive Product Launch and Marketing Strategies

Health and fitness leaders Jack Seitz and Lara Rosenbaum join CONNEQT’s executive team, bringing a combined 45 years of digital health marketing talent IRVINE, Calif., April 4, 2022 /PRNewswire/ — CardieX Limited (ASX: CDX), a global health technology company focused on cardiovascular disease and vascular health disorders, today announces the addition of notable experts in the health and fitness […]

HeartFlow Appoints Monica Tellado as CFO

MOUNTAIN VIEW, Calif., April 04, 2022 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced that Monica Tellado has been appointed Chief Financial Officer (CFO), effective April 4, 2022. “Monica is a high-impact leader with an outstanding track record of delivering results and creating value,” said […]

Hyloris Successfully Raises EUR 15.0 Million in an Equity Offering by Means of A Private Placement Via an Accelerated Bookbuild Offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 1 April 2022, 07:00 CET LIÈGE, Belgium , April 01, […]

Alberto Mas Announces Intent to Retire from BD at End of Fiscal Year

FRANKLIN LAKES, N.J., March 31, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Alberto Mas has informed the company of his intent to retire from BD, effective at the end of the company’s fiscal year on Sept. 30, 2022. Mas, 60, is currently executive vice […]

4C Medical Technologies Completes $35 Million Series C Financing and Appoints Saravana Kumar as President and CEO

MINNEAPOLIS, March 31, 2022 /PRNewswire/ — 4C Medical Technologies, Inc. (“4C Medical” or the “Company”), a privately-held medical technology company focused on the development of minimally invasive therapies for structural heart disease, announced that it has completed a $35.4 million Series C Preferred Stock financing.  The Series C round was led by MicroPort CardioFlow Medtech Corporation […]

LifeTech Scientific Corporation(1302.HK) Announces 2021 Annual Results

Excluding certain non-recurring items, the net profit attributable to owners of the Company increased by  76.8% to RMB 324.0million SHENZHEN, China, March 30, 2022 /PRNewswire/ — LifeTech Scientific Corporation (LifeTech, 1302.HK), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced 2021 annual results. During the year ended 31 December 2021, […]

UPDATE – Hyloris Launches Equity Offering by Means of a Private Placement Via an Accelerated Bookbuild Offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.  REGULATED INFORMATION – INSIDE INFORMATION LIÈGE, Belgium, March 31, 2022 (GLOBE NEWSWIRE) — Hyloris Pharmaceuticals SA (Euronext Brussels: […]

Windtree Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Key Business Updates

WARRINGTON, Pa., March 31, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today reported financial results for the fourth quarter and year ended December 31, 2021 and provided key business updates. “This past quarter […]